PD-L2 overexpression indicates a poor prognosis in head and neck squamous cell carcinoma (HNSCC) [36], adenoid cystic carcinoma [37], and oesophageal cancer [38]. This evidence concerns the gene PDCD1LG2 and adenoid cystic carcinoma.